VMD vs. AGL, PNTG, AVAH, CDNA, SBC, PSNL, FLGT, INNV, CELC, and LFMD
Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include Agilon Health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), CareDx (CDNA), SBC Medical Group (SBC), Personalis (PSNL), Fulgent Genetics (FLGT), InnovAge (INNV), Celcuity (CELC), and LifeMD (LFMD). These companies are all part of the "healthcare" industry.
Viemed Healthcare vs. Its Competitors
Agilon Health (NYSE:AGL) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.
Agilon Health currently has a consensus price target of $4.71, suggesting a potential upside of 128.29%. Given Agilon Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Agilon Health is more favorable than Viemed Healthcare.
74.2% of Viemed Healthcare shares are owned by institutional investors. 3.6% of Agilon Health shares are owned by insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Viemed Healthcare has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Agilon Health had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for Agilon Health and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.22 beat Agilon Health's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the news media.
Agilon Health has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.
Viemed Healthcare has a net margin of 5.28% compared to Agilon Health's net margin of -4.04%. Viemed Healthcare's return on equity of 9.49% beat Agilon Health's return on equity.
Summary
Viemed Healthcare beats Agilon Health on 11 of the 16 factors compared between the two stocks.
Get Viemed Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viemed Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:VMD) was last updated on 7/25/2025 by MarketBeat.com Staff
Free VMD Stock Alerts